Blackstone-Backed Catalent Plans $629M Follow-On Offering
New Jersey-based drug development and delivery company Catalent Inc. on Friday unveiled plans for a follow-on offering to raise $629.3 million for the company's backers, including Blackstone Group LP, as they...To view the full article, register now.
Already a subscriber? Click here to view full article